TriSalus Life Sciences today announced positive clinical results for its Pressure-Enabled Regional Immuno-Oncology technology. The company, currently in the process of going public through a SPAC merger, filed a presentation for investors. It features information regarding its ongoing PERIO 01 and PERIO 02 clinical studies. The studies evaluate the TriNav pressure-enabled drug delivery technology for […]
Mergers & Acquisitions
B. Braun buys catheter securement device portfolio from Starboard
B. Braun Medical announced today that it acquired the Clik-FIX catheter securement device portfolio from Starboard Medical. Clik-FIX adds to B.Braun’s offerings that help improve patient experiences and outcomes for peripheral intravenous (IV) therapy. Get the full story at our sister site, MassDevice.
Second Sight Medical merges with Nano Precision Medical, rebrands as Vivani Medical
Second Sight Medical (Nasdaq:EYES) announced today that it completed its merger with Nano Precision Medical and rebranded. In February, the two companies entered into a definitive agreement under which Nano Precision Medical (NPM) would merge with a wholly-owned subsidiary of Second Sight in an all-stock transaction, with NPM as the surviving company under Second Sight’s […]
Aptar acquires Orbital dry powder inhaler license
Aptar Pharma announced today that it acquired the worldwide writes to Pharmaxis’ proprietary Orbital inhaler. Pharmaxis designed its Orbital technology to deliver high-payload dry powder to the lungs, helping to meet the need to deliver high doses of drugs such as antibiotics. According to a news release, the Orbital inhaler allows payloads of up to […]
BD buys MedKeeper and its connected pharmacy software for IV workflow
BD (NYSE:BD) announced today that it acquired cloud-based pharmacy management application developer MedKeeper. Franklin Lakes, N.J.-based BD said in a news release that MedKeeper strategically complements its existing presence in the pharmacy, with solutions for compounding, logistics workflow, controlled substance management and inventory optimization. MedKeeper’s platform will be made part of BD’s existing portfolio of […]
Tandem Diabetes Care acquires infusion set maker Capillary Biomedical
Tandem Diabetes Care (Nasdaq:TNDM) announced that it acquired infusion set developer Capillary Biomedical. San Diego-based Tandem, a global insulin delivery and diabetes technology company, announced its intention to acquire Irvine, California-based Capillary last week. Financial terms for the deal were not disclosed. “Infusion sets provide people flexible options in insulin pump wearability, and we are […]
AbbVie enters partnership with iStar with option to acquire
AbbVie (NYSE:ABBV) announced today that it entered into a strategic alliance with iStar Medical over the MINIject device. The strategic transaction centers around helping to further develop and commercialize iStar’s MINIject minimally invasive glaucoma surgical (MIGS) device. It will also provide AbbVie with a chance to expand its eye care business through an option to […]
Vertex to acquire stem cell-derived diabetes treatment maker ViaCyte for $320M
Vertex Pharmaceuticals (Nasdaq:VRTX) announced today that it agreed to acquire ViaCyte for $320 million. San Diego-based ViaCyte develops an advanced portfolio of novel stem cell-derived replacement therapies designed to provide a functional cure for patients with type 1 diabetes. Boston-based Vertex develops its own similar therapeutic for diabetes, having designed its VX-880 as a stem […]
Dexcom quashes talk of Insulet merger, says discussions are not ongoing
Dexcom (Nasdaq:DXCM) today issued a statement denying recent rumors of a potential merger with Insulet (Nasdaq:PODD). Last week, reports circulated saying talks over a potential acquisition were ongoing, with an agreement between the two diabetes technology developers on the horizon in the coming weeks. On the back of the Dexcom statement, DXCM shares were up 7% at $308.87 apiece […]
Report: Dexcom in talks to acquire Insulet
Major players in the diabetes space could join forces as Dexcom (Nasdaq:DXCM) is reportedly in discussions to acquire Insulet (Nasdaq:PODD). Bloomberg reported today that people “with knowledge of the matter” have said talks are ongoing over a potential acquisition and even said an agreement could be reached “in the coming weeks.” Bloomberg said its sources preferred […]
